Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Harvard Business School
McKinsey
Johnson and Johnson
Express Scripts

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Innogenix Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for INNOGENIX, and what generic and branded alternatives to INNOGENIX drugs are available?

INNOGENIX has five approved drugs.



Summary for Innogenix
US Patents:0
Tradenames:5
Ingredients:5
NDAs:5

Drugs and US Patents for Innogenix

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Innogenix PILOCARPINE HYDROCHLORIDE pilocarpine hydrochloride TABLET;ORAL 076963-001 Dec 22, 2004 AB RX No No   Start Trial   Start Trial
Innogenix LABETALOL HYDROCHLORIDE labetalol hydrochloride TABLET;ORAL 075215-003 Jul 29, 1999 AB RX No No   Start Trial   Start Trial
Innogenix METRONIDAZOLE metronidazole TABLET;ORAL 070772-001 Jul 16, 1986 AB RX No No   Start Trial   Start Trial
Innogenix LABETALOL HYDROCHLORIDE labetalol hydrochloride TABLET;ORAL 075215-001 Jul 29, 1999 AB RX No No   Start Trial   Start Trial
Innogenix HALOPERIDOL haloperidol TABLET;ORAL 071173-002 Jan 2, 1987 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Baxter
Colorcon
Mallinckrodt
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.